Phase I/II study of gemcitabine as a fixed dose rate infusion and S-1 combination therapy (FGS) in gemcitabine-refractory pancreatic cancer patients
2011 ◽
Vol 69
(4)
◽
pp. 957-964
◽
Keyword(s):
Phase I
◽
2004 ◽
Vol 22
(14_suppl)
◽
pp. 4011-4011
◽
2004 ◽
Vol 22
(14_suppl)
◽
pp. 4011-4011